HOB Biotech Group Corp.,Ltd Stock
Equities
688656
CNE100004C37
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
23.65 CNY | +1.98% | +12.09% | -31.96% |
Mar. 11 | HOB Biotech Group Corp.,Ltd announces an Equity Buyback for CNY 30 million worth of its shares. | CI |
Mar. 08 | HOB Biotech Group Corp.,Ltd authorizes a Buyback Plan. | CI |
Sales 2021 | 318M 43.85M | Sales 2022 | 320M 44.22M | Capitalization | 2.11B 292M |
---|---|---|---|---|---|
Net income 2021 | 86M 11.87M | Net income 2022 | 41M 5.66M | EV / Sales 2021 | 11.2 x |
Net cash position 2021 | 424M 58.52M | Net cash position 2022 | 224M 30.86M | EV / Sales 2022 | 5.9 x |
P/E ratio 2021 |
45
x | P/E ratio 2022 |
50.8
x | Employees | 488 |
Yield 2021 |
0.84% | Yield 2022 |
0.89% | Free-Float | 20.83% |
1 day | +1.98% | ||
1 week | +12.09% | ||
Current month | -9.84% | ||
1 month | -11.02% | ||
3 months | -15.78% | ||
6 months | -37.15% | ||
Current year | -31.96% |
Managers | Title | Age | Since |
---|---|---|---|
John Li
CEO | Chief Executive Officer | 61 | 06-12-31 |
Shu Yan Han
DFI | Director of Finance/CFO | 44 | 23-07-06 |
Hai Yun Jiao
CHM | Chairman | 46 | 15-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Li
CEO | Chief Executive Officer | 61 | 06-12-31 |
Hai Yun Jiao
CHM | Chairman | 46 | 15-03-31 |
Kai Wang
BRD | Director/Board Member | 60 | 13-09-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 23.65 | +1.98% | 368,224 |
24-04-23 | 23.19 | +0.22% | 475,302 |
24-04-22 | 23.14 | +2.89% | 385,745 |
24-04-19 | 22.49 | -1.01% | 263,207 |
24-04-18 | 22.72 | +1.70% | 388,113 |
End-of-day quote Shanghai S.E., April 23, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-31.96% | 202M | |
-2.89% | 187B | |
-2.43% | 108B | |
-4.10% | 67.71B | |
+11.10% | 53.07B | |
+15.86% | 47.36B | |
+6.01% | 39.73B | |
+9.55% | 28.56B | |
+1.85% | 26.55B | |
+15.97% | 25.13B |
- Stock Market
- Equities
- 688656 Stock